M Cave
Concepts (299)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 78 | 2013 | 285 | 5.510 |
Why?
| Tuberculosis | 41 | 2011 | 146 | 3.200 |
Why?
| DNA Fingerprinting | 28 | 2007 | 62 | 2.060 |
Why?
| DNA Transposable Elements | 31 | 2006 | 107 | 1.860 |
Why?
| DNA, Bacterial | 30 | 2007 | 188 | 1.130 |
Why?
| Tuberculosis, Pulmonary | 19 | 2013 | 107 | 1.120 |
Why?
| Polymorphism, Restriction Fragment Length | 28 | 2013 | 66 | 1.040 |
Why?
| Antitubercular Agents | 14 | 2013 | 106 | 0.620 |
Why?
| Bacterial Typing Techniques | 8 | 2007 | 39 | 0.590 |
Why?
| Salmonella | 3 | 2004 | 26 | 0.560 |
Why?
| Molecular Epidemiology | 8 | 2011 | 39 | 0.480 |
Why?
| Polymorphism, Genetic | 10 | 2008 | 181 | 0.480 |
Why?
| Polymerase Chain Reaction | 17 | 2007 | 454 | 0.440 |
Why?
| Salmonella Infections | 3 | 2004 | 16 | 0.440 |
Why?
| Genotype | 16 | 2013 | 534 | 0.390 |
Why?
| Tuberculosis, Multidrug-Resistant | 5 | 2006 | 40 | 0.390 |
Why?
| Disease Outbreaks | 6 | 2007 | 125 | 0.380 |
Why?
| Macrophages | 4 | 2007 | 363 | 0.380 |
Why?
| Bacterial Proteins | 12 | 2008 | 376 | 0.350 |
Why?
| Type C Phospholipases | 3 | 2006 | 14 | 0.340 |
Why?
| Salmonella typhimurium | 2 | 2006 | 48 | 0.340 |
Why?
| Repetitive Sequences, Nucleic Acid | 11 | 2006 | 96 | 0.310 |
Why?
| Genes, Bacterial | 7 | 2008 | 64 | 0.310 |
Why?
| Sequence Analysis, DNA | 11 | 2008 | 238 | 0.310 |
Why?
| Humans | 79 | 2013 | 50208 | 0.310 |
Why?
| Minisatellite Repeats | 2 | 2006 | 5 | 0.300 |
Why?
| Th1 Cells | 1 | 2007 | 52 | 0.290 |
Why?
| Sputum | 11 | 2013 | 65 | 0.290 |
Why?
| Cluster Analysis | 13 | 2011 | 235 | 0.270 |
Why?
| Rifampin | 6 | 2013 | 62 | 0.270 |
Why?
| Chromosome Mapping | 4 | 2008 | 156 | 0.270 |
Why?
| Antigens, Bacterial | 5 | 2008 | 54 | 0.260 |
Why?
| Urban Health | 2 | 2013 | 31 | 0.260 |
Why?
| Arkansas | 13 | 2011 | 1985 | 0.260 |
Why?
| Risk Factors | 14 | 2013 | 3629 | 0.250 |
Why?
| Prisoners | 2 | 2004 | 89 | 0.250 |
Why?
| False Positive Reactions | 3 | 2001 | 62 | 0.240 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 6 | 2006 | 29 | 0.240 |
Why?
| Adult | 31 | 2013 | 13324 | 0.240 |
Why?
| Mutation | 4 | 2006 | 1294 | 0.230 |
Why?
| Base Sequence | 18 | 2005 | 644 | 0.230 |
Why?
| Tuberculin Test | 2 | 2002 | 9 | 0.230 |
Why?
| Male | 39 | 2013 | 25399 | 0.220 |
Why?
| Campylobacter | 1 | 2002 | 5 | 0.210 |
Why?
| Campylobacter Infections | 1 | 2002 | 9 | 0.210 |
Why?
| Gryllidae | 3 | 1987 | 5 | 0.210 |
Why?
| Orthoptera | 3 | 1987 | 5 | 0.210 |
Why?
| Drug Resistance, Multiple | 2 | 2001 | 24 | 0.200 |
Why?
| RNA, Ribosomal | 4 | 1987 | 20 | 0.200 |
Why?
| Laboratories, Hospital | 1 | 2001 | 6 | 0.200 |
Why?
| Middle Aged | 26 | 2011 | 12206 | 0.200 |
Why?
| Genome, Bacterial | 6 | 2006 | 125 | 0.200 |
Why?
| Chickens | 1 | 2002 | 110 | 0.200 |
Why?
| Equipment Contamination | 1 | 2001 | 18 | 0.200 |
Why?
| Laboratories | 1 | 2001 | 21 | 0.200 |
Why?
| Female | 36 | 2013 | 26635 | 0.190 |
Why?
| DNA Probes | 4 | 1997 | 30 | 0.190 |
Why?
| AIDS-Related Opportunistic Infections | 5 | 2000 | 40 | 0.180 |
Why?
| Mycobacterium bovis | 4 | 2000 | 11 | 0.180 |
Why?
| Membrane Proteins | 3 | 2008 | 353 | 0.180 |
Why?
| Molecular Sequence Data | 15 | 2005 | 793 | 0.180 |
Why?
| Gene Deletion | 5 | 2008 | 270 | 0.170 |
Why?
| Mass Screening | 1 | 2002 | 346 | 0.170 |
Why?
| Genetic Variation | 6 | 2011 | 213 | 0.170 |
Why?
| Aged | 17 | 2011 | 9405 | 0.160 |
Why?
| Environmental Microbiology | 1 | 1999 | 7 | 0.160 |
Why?
| Salmonella Food Poisoning | 1 | 1998 | 6 | 0.160 |
Why?
| Colorado | 4 | 2007 | 21 | 0.160 |
Why?
| Plasmids | 3 | 1996 | 161 | 0.150 |
Why?
| Blotting, Southern | 5 | 2005 | 42 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 5 | 2007 | 485 | 0.140 |
Why?
| Genes | 5 | 1987 | 33 | 0.140 |
Why?
| Adolescent | 12 | 2008 | 6390 | 0.140 |
Why?
| Incidence | 6 | 2013 | 1006 | 0.140 |
Why?
| DNA, Ribosomal | 2 | 1986 | 28 | 0.130 |
Why?
| RNA, Messenger | 4 | 1999 | 1108 | 0.120 |
Why?
| Sensitivity and Specificity | 7 | 2005 | 863 | 0.120 |
Why?
| Diet | 1 | 1998 | 557 | 0.120 |
Why?
| Evolution, Molecular | 2 | 2006 | 99 | 0.120 |
Why?
| Isoniazid | 5 | 2006 | 37 | 0.110 |
Why?
| Endemic Diseases | 1 | 2013 | 22 | 0.110 |
Why?
| Bacteriological Techniques | 6 | 1998 | 41 | 0.110 |
Why?
| Contact Tracing | 2 | 2002 | 8 | 0.110 |
Why?
| Microbial Sensitivity Tests | 6 | 2006 | 270 | 0.110 |
Why?
| Serotyping | 2 | 2004 | 12 | 0.100 |
Why?
| Evaluation Studies as Topic | 6 | 1996 | 110 | 0.100 |
Why?
| Child, Preschool | 9 | 2008 | 3883 | 0.100 |
Why?
| Mycobacterium | 7 | 1998 | 28 | 0.100 |
Why?
| Los Angeles | 4 | 1999 | 30 | 0.100 |
Why?
| RNA, Bacterial | 4 | 1999 | 58 | 0.100 |
Why?
| Gene Amplification | 4 | 1998 | 57 | 0.090 |
Why?
| Child | 9 | 2008 | 6851 | 0.090 |
Why?
| Food Microbiology | 2 | 2002 | 49 | 0.090 |
Why?
| Prospective Studies | 7 | 2004 | 2379 | 0.090 |
Why?
| Infant | 7 | 2008 | 3563 | 0.090 |
Why?
| Population Surveillance | 3 | 2007 | 164 | 0.090 |
Why?
| Retrospective Studies | 7 | 2013 | 6134 | 0.090 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 388 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 595 | 0.090 |
Why?
| Species Specificity | 7 | 2006 | 192 | 0.090 |
Why?
| Host-Pathogen Interactions | 1 | 2011 | 135 | 0.080 |
Why?
| Drug Resistance, Bacterial | 3 | 2005 | 71 | 0.080 |
Why?
| Ethambutol | 2 | 2006 | 8 | 0.080 |
Why?
| Acyltransferases | 2 | 1999 | 29 | 0.080 |
Why?
| Esterases | 1 | 2008 | 1 | 0.080 |
Why?
| Hydrolases | 1 | 2008 | 7 | 0.080 |
Why?
| Housing | 2 | 1999 | 45 | 0.080 |
Why?
| Time Factors | 6 | 2013 | 2922 | 0.080 |
Why?
| Seroepidemiologic Studies | 2 | 2007 | 43 | 0.080 |
Why?
| Aged, 80 and over | 6 | 2008 | 3154 | 0.080 |
Why?
| Monocytes | 3 | 2006 | 131 | 0.080 |
Why?
| Nucleic Acid Amplification Techniques | 2 | 1999 | 14 | 0.080 |
Why?
| Antibiotics, Antitubercular | 3 | 2006 | 17 | 0.070 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 244 | 0.070 |
Why?
| Phagocytes | 1 | 2006 | 12 | 0.070 |
Why?
| Cloning, Molecular | 5 | 1996 | 186 | 0.070 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2004 | 63 | 0.070 |
Why?
| Biological Evolution | 1 | 2006 | 32 | 0.070 |
Why?
| Oligonucleotides | 3 | 2004 | 81 | 0.070 |
Why?
| Genetic Markers | 2 | 2005 | 102 | 0.070 |
Why?
| United States | 5 | 2004 | 4874 | 0.070 |
Why?
| Multigene Family | 3 | 2006 | 56 | 0.070 |
Why?
| Urban Population | 3 | 2002 | 150 | 0.060 |
Why?
| Cytokines | 2 | 2006 | 613 | 0.060 |
Why?
| Virulence | 4 | 2008 | 173 | 0.060 |
Why?
| Mexico | 2 | 2004 | 36 | 0.060 |
Why?
| DNA Replication | 2 | 1976 | 150 | 0.060 |
Why?
| Water Microbiology | 1 | 2004 | 29 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2004 | 695 | 0.060 |
Why?
| Rural Population | 3 | 2007 | 537 | 0.060 |
Why?
| Genetic Techniques | 1 | 2003 | 14 | 0.060 |
Why?
| Uganda | 3 | 2013 | 36 | 0.060 |
Why?
| Base Composition | 2 | 2000 | 28 | 0.060 |
Why?
| Communicable Disease Control | 1 | 2003 | 39 | 0.060 |
Why?
| Reproducibility of Results | 3 | 2002 | 1185 | 0.050 |
Why?
| Drug Resistance, Microbial | 4 | 1999 | 46 | 0.050 |
Why?
| Food Contamination | 1 | 2002 | 37 | 0.050 |
Why?
| Computer Simulation | 1 | 2003 | 280 | 0.050 |
Why?
| Disease Progression | 1 | 2005 | 831 | 0.050 |
Why?
| Animals | 9 | 2002 | 13246 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2005 | 951 | 0.050 |
Why?
| Hospitals, Public | 1 | 2001 | 7 | 0.050 |
Why?
| Nursing Homes | 1 | 2002 | 114 | 0.050 |
Why?
| Occupational Diseases | 1 | 2002 | 88 | 0.050 |
Why?
| Hospitals, University | 1 | 2001 | 77 | 0.050 |
Why?
| Confidence Intervals | 1 | 2001 | 156 | 0.050 |
Why?
| Probability | 1 | 2001 | 164 | 0.050 |
Why?
| Logistic Models | 2 | 2006 | 889 | 0.040 |
Why?
| Spain | 2 | 1997 | 17 | 0.040 |
Why?
| Recurrence | 3 | 2013 | 662 | 0.040 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2000 | 22 | 0.040 |
Why?
| Case-Control Studies | 2 | 2003 | 1126 | 0.040 |
Why?
| Odds Ratio | 1 | 2001 | 546 | 0.040 |
Why?
| Cross Infection | 1 | 2000 | 93 | 0.040 |
Why?
| Infant, Newborn | 4 | 2008 | 2766 | 0.040 |
Why?
| Histocytological Preparation Techniques | 1 | 1998 | 2 | 0.040 |
Why?
| DNA Restriction Enzymes | 3 | 1992 | 19 | 0.040 |
Why?
| Multivariate Analysis | 2 | 2013 | 581 | 0.040 |
Why?
| Databases, Factual | 1 | 2001 | 657 | 0.040 |
Why?
| Gene Expression | 1 | 2000 | 609 | 0.040 |
Why?
| HIV Infections | 3 | 2013 | 357 | 0.040 |
Why?
| DNA Primers | 4 | 1999 | 207 | 0.040 |
Why?
| Radiography, Thoracic | 1 | 1997 | 65 | 0.040 |
Why?
| Phylogeny | 3 | 2005 | 234 | 0.040 |
Why?
| Molecular Probe Techniques | 1 | 1996 | 9 | 0.040 |
Why?
| Analysis of Variance | 1 | 1998 | 564 | 0.040 |
Why?
| Mycobacterium avium | 3 | 1998 | 8 | 0.040 |
Why?
| Bombyx | 1 | 1976 | 2 | 0.030 |
Why?
| Sigma Factor | 1 | 1996 | 22 | 0.030 |
Why?
| Diagnostic Errors | 1 | 1997 | 63 | 0.030 |
Why?
| Mutagenesis, Insertional | 2 | 2005 | 24 | 0.030 |
Why?
| Hemiptera | 1 | 1975 | 4 | 0.030 |
Why?
| Risk Assessment | 2 | 2013 | 1262 | 0.030 |
Why?
| Repressor Proteins | 1 | 1996 | 153 | 0.030 |
Why?
| Restriction Mapping | 2 | 1993 | 32 | 0.030 |
Why?
| Chi-Square Distribution | 2 | 2007 | 278 | 0.030 |
Why?
| Nucleic Acid Hybridization | 2 | 1991 | 54 | 0.030 |
Why?
| Drug Therapy, Combination | 3 | 2000 | 381 | 0.030 |
Why?
| Urine | 1 | 1994 | 23 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 1996 | 428 | 0.030 |
Why?
| Amplified Fragment Length Polymorphism Analysis | 1 | 2013 | 3 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1998 | 48 | 0.030 |
Why?
| Coinfection | 1 | 2013 | 38 | 0.030 |
Why?
| Transcription Factors | 1 | 1996 | 564 | 0.030 |
Why?
| Age Factors | 2 | 2007 | 1092 | 0.030 |
Why?
| Lung | 1 | 1996 | 490 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2013 | 410 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2013 | 465 | 0.020 |
Why?
| Risk | 2 | 2002 | 324 | 0.020 |
Why?
| Alleles | 2 | 2006 | 251 | 0.020 |
Why?
| Washington | 2 | 2006 | 47 | 0.020 |
Why?
| Autoradiography | 1 | 1991 | 33 | 0.020 |
Why?
| HIV Seropositivity | 1 | 2011 | 27 | 0.020 |
Why?
| Interdisciplinary Communication | 1 | 2011 | 55 | 0.020 |
Why?
| Texas | 2 | 2002 | 139 | 0.020 |
Why?
| Phenotype | 1 | 2013 | 733 | 0.020 |
Why?
| Epidemiologic Methods | 3 | 1997 | 49 | 0.020 |
Why?
| Cells, Cultured | 2 | 2006 | 1581 | 0.020 |
Why?
| Colony Count, Microbial | 2 | 1999 | 66 | 0.020 |
Why?
| Molecular Weight | 2 | 1985 | 85 | 0.020 |
Why?
| Poisson Distribution | 1 | 2007 | 34 | 0.020 |
Why?
| RNA, Ribosomal, 16S | 2 | 1999 | 112 | 0.020 |
Why?
| Frameshift Mutation | 1 | 2007 | 17 | 0.020 |
Why?
| Peptide Mapping | 1 | 2007 | 22 | 0.020 |
Why?
| Paraffin Embedding | 2 | 1998 | 53 | 0.020 |
Why?
| West Virginia | 1 | 2007 | 2 | 0.020 |
Why?
| Montana | 1 | 2007 | 7 | 0.020 |
Why?
| New Hampshire | 1 | 2007 | 4 | 0.020 |
Why?
| Iowa | 1 | 2007 | 23 | 0.020 |
Why?
| Treatment Outcome | 2 | 2013 | 5155 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 45 | 0.020 |
Why?
| Streptomycin | 1 | 2006 | 10 | 0.020 |
Why?
| DNA, Intergenic | 1 | 2006 | 7 | 0.020 |
Why?
| China | 1 | 2006 | 88 | 0.020 |
Why?
| Family Characteristics | 1 | 2006 | 50 | 0.020 |
Why?
| Open Reading Frames | 1 | 2006 | 55 | 0.020 |
Why?
| Coculture Techniques | 1 | 2006 | 146 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2006 | 176 | 0.020 |
Why?
| Geography | 1 | 2006 | 60 | 0.020 |
Why?
| Testis | 2 | 1976 | 69 | 0.020 |
Why?
| Ovary | 2 | 1976 | 115 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1986 | 369 | 0.020 |
Why?
| Cell Nucleus | 2 | 1976 | 187 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 411 | 0.020 |
Why?
| Interleukin-10 | 1 | 2004 | 84 | 0.020 |
Why?
| Canada | 1 | 2004 | 101 | 0.010 |
Why?
| Leukemia, Monocytic, Acute | 1 | 2004 | 5 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2004 | 46 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2006 | 475 | 0.010 |
Why?
| Escherichia coli | 1 | 1985 | 186 | 0.010 |
Why?
| Age Distribution | 1 | 2003 | 168 | 0.010 |
Why?
| Interferon-gamma | 1 | 2004 | 176 | 0.010 |
Why?
| Least-Squares Analysis | 1 | 2002 | 43 | 0.010 |
Why?
| Hospitals, Community | 1 | 2002 | 19 | 0.010 |
Why?
| Photography | 1 | 2002 | 32 | 0.010 |
Why?
| Rural Health | 1 | 2002 | 88 | 0.010 |
Why?
| Algorithms | 1 | 2006 | 618 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2002 | 193 | 0.010 |
Why?
| Cell Line | 1 | 2004 | 1021 | 0.010 |
Why?
| Nontuberculous Mycobacteria | 1 | 1981 | 12 | 0.010 |
Why?
| Computational Biology | 1 | 2003 | 216 | 0.010 |
Why?
| Sex Factors | 1 | 2003 | 697 | 0.010 |
Why?
| DNA, Viral | 2 | 1997 | 134 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2004 | 1416 | 0.010 |
Why?
| Nitrites | 1 | 1999 | 31 | 0.010 |
Why?
| Interleukins | 1 | 1999 | 32 | 0.010 |
Why?
| Immunocompromised Host | 1 | 2000 | 119 | 0.010 |
Why?
| Young Adult | 1 | 2008 | 3981 | 0.010 |
Why?
| Half-Life | 1 | 1999 | 87 | 0.010 |
Why?
| Fixatives | 1 | 1998 | 13 | 0.010 |
Why?
| Culture Media | 1 | 1999 | 93 | 0.010 |
Why?
| Chromosomes, Bacterial | 1 | 1998 | 14 | 0.010 |
Why?
| Mycobacterium Infections | 1 | 1998 | 12 | 0.010 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2000 | 92 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2002 | 1043 | 0.010 |
Why?
| Formaldehyde | 1 | 1998 | 52 | 0.010 |
Why?
| Coloring Agents | 1 | 1998 | 70 | 0.010 |
Why?
| San Francisco | 1 | 1998 | 11 | 0.010 |
Why?
| Binding, Competitive | 1 | 1998 | 94 | 0.010 |
Why?
| Granuloma | 1 | 1998 | 44 | 0.010 |
Why?
| Emigration and Immigration | 1 | 1998 | 17 | 0.010 |
Why?
| Disease Transmission, Infectious | 1 | 1998 | 13 | 0.010 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2000 | 185 | 0.010 |
Why?
| Substance Abuse, Intravenous | 1 | 1998 | 43 | 0.010 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 54 | 0.010 |
Why?
| HIV | 1 | 1997 | 24 | 0.010 |
Why?
| Demography | 1 | 1997 | 92 | 0.010 |
Why?
| Alkalies | 1 | 1996 | 4 | 0.010 |
Why?
| Mycobacterium leprae | 1 | 1996 | 8 | 0.010 |
Why?
| Sequence Homology | 1 | 1996 | 20 | 0.010 |
Why?
| Health Personnel | 1 | 2000 | 254 | 0.010 |
Why?
| Exocrine Glands | 1 | 1976 | 1 | 0.010 |
Why?
| Cell Nucleolus | 1 | 1976 | 4 | 0.010 |
Why?
| Guanosine | 1 | 1996 | 6 | 0.010 |
Why?
| Polyploidy | 1 | 1976 | 11 | 0.010 |
Why?
| Medical Records | 1 | 1997 | 83 | 0.010 |
Why?
| Nucleic Acids | 1 | 1976 | 13 | 0.010 |
Why?
| Cattle | 1 | 1996 | 219 | 0.010 |
Why?
| Alcohol Drinking | 1 | 1998 | 226 | 0.010 |
Why?
| Tissue Fixation | 1 | 1996 | 37 | 0.010 |
Why?
| Adenosine | 1 | 1996 | 70 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 1998 | 905 | 0.010 |
Why?
| DNA, Satellite | 1 | 1975 | 11 | 0.010 |
Why?
| Guanine | 1 | 1975 | 40 | 0.010 |
Why?
| Cytosine | 1 | 1975 | 30 | 0.010 |
Why?
| Mummies | 1 | 1995 | 2 | 0.010 |
Why?
| History, Medieval | 1 | 1995 | 5 | 0.010 |
Why?
| Peru | 1 | 1995 | 8 | 0.010 |
Why?
| History, Ancient | 1 | 1995 | 9 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1996 | 586 | 0.010 |
Why?
| Oocytes | 1 | 1975 | 74 | 0.010 |
Why?
| Fatal Outcome | 1 | 1995 | 195 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2000 | 2190 | 0.010 |
Why?
| DNA | 1 | 1975 | 541 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2000 | 1186 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1990 | 11 | 0.010 |
Why?
| Temperature | 1 | 1990 | 168 | 0.010 |
Why?
| Mice | 1 | 1996 | 5759 | 0.000 |
Why?
| Bacteriophage Typing | 1 | 1981 | 1 | 0.000 |
Why?
|
|
Cave's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|